Institutional investors hold a majority ownership of MYL through the 84.25% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2015, these large investors purchased a net $65.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK INVESTMENT MANAGEMENT ... Bought 29.7 Million shares of Mylan NV
WELLINGTON MANAGEMENT CO. LLP Bought 18.1 Million shares of Mylan NV
LAZARD ASSET MANAGEMENT LTD. Bought 7.2 Million shares of Mylan NV